Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan Hydrochloride”

1,181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,181 results

Early research (Phase 1)Study completedNCT00003742
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01876446
What this trial is testing

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
Roswell Park Cancer Institute 38
Testing effectiveness (Phase 2)Study completedNCT00004922
What this trial is testing

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Carcinoma of Unknown PrimaryNeuroendocrine CarcinomaNeuroendocrine Carcinoma of the Skin
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00109850
What this trial is testing

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 22
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00276692
What this trial is testing

Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Cancer and Leukaemia Group 35
Testing effectiveness (Phase 2)UnknownNCT01380275
What this trial is testing

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Who this might be right for
Sarcoma
National Cancer Center, Korea 35
Testing effectiveness (Phase 2)Study completedNCT00165464
What this trial is testing

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric CancerGE Junction Cancer
Dana-Farber Cancer Institute 54
Testing effectiveness (Phase 2)Study completedNCT00139711
What this trial is testing

Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 138
Testing effectiveness (Phase 2)Study completedNCT01123811
What this trial is testing

Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer

Who this might be right for
Adenocarcinoma of Stomach or Esophagogastric Junction
Johannes Gutenberg University Mainz 45
Testing effectiveness (Phase 2)Study completedNCT01312857
What this trial is testing

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT04617457
What this trial is testing

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerMetastasisSurgery+1 more
University of Cologne 150
Testing effectiveness (Phase 2)Looking for participantsNCT06242067
What this trial is testing

Second-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Hospital of Shandong University 50
Early research (Phase 1)Study completedNCT00695201
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 52
Large-scale testing (Phase 3)Active Not RecruitingNCT04927780
What this trial is testing

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaResectable Pancreatic Adenocarcinoma
Erasmus Medical Center 378
Testing effectiveness (Phase 2)UnknownNCT03613753
What this trial is testing

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
ShengFa Su 72
Testing effectiveness (Phase 2)Ended earlyNCT01042028
What this trial is testing

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 39
Testing effectiveness (Phase 2)UnknownNCT02591667
What this trial is testing

Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer

Who this might be right for
Colorectal CancerPeritoneal Metastasis
Medical University of Vienna 30
Testing effectiveness (Phase 2)Study completedNCT00617539
What this trial is testing

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

Who this might be right for
Breast CancerMetastatic Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)UnknownNCT01859728
What this trial is testing

GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer

Who this might be right for
Biliary Cancer
Hospital de Cancer de Barretos - Fundacao Pio XII 48
Next Page